Lou Panaccio - 05 Jun 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: Director
Signature: /s/ Donna Shiroma
Issuer symbol: RCEL
Transactions as of: 05 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2024, 20:48:06 UTC
Previous filing: 08 Jun 2023
Next filing: 05 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award		+9,200	+25%		46,406	05 Jun 2024	Direct	F1, F2, F3
holding	RCEL	Common Stock						5,972	05 Jun 2024	See footnote	F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+3,943		$0.000000	3,943	05 Jun 2024	Common Stock	3,943	$9.51	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.
F2	Includes unvested RSUs.
F3	Includes 70,460 of the Issuer's CDIs. The Reporting Person holds 70,460 CDIs, which translate into 14,092 of the shares of Common Stock set forth above.
F4	Reflects 29,860 CDIs, which translate into the 5,972 shares of Common Stock set forth above.
F5	These CDIs are held by The Panaccio Superannuation Fund (the "Fund"). The Reporting Person is a director of Tercus Pty Ltd, trustee of the Fund, and is a beneficiary of the Fund. The Reporting Person may be deemed to have shared voting and dispositive power over the CDIs held by the Fund but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein.